Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating AP203 in patients with locally advanced or metastatic solid tumors, including non-small cell lung cancer and sele…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Or Metastatic Solid Tumors

Drugs mentioned

• AP203 (AP203)

Snippet

Sponsor: AP Biosciences Inc. | Conditions: Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: RECRUITING